Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Pregnancy Does Not Prove Neuroprotective for Women with MS Who Stop Taking Natalizumab
Frontrunners of T cell activation: Initial, localized Ca2+ signals mediated by NAADP and the type 1 ryanodine receptor.
[Acute transverse myelitis].
Monitoring oligoclonal immunoglobulins in cerebral spinal fluid using microLC-ESI-Q-TOF mass spectrometry.
[A DTI study of the spinal cord lesion in patients with multiple sclerosis during the follow-up after relapse].
Drugs in clinical development for multiple sclerosis: focusing on anti-CD20 antibodies.
Speed of word retrieval in multiple sclerosis.
Assessing risks of multiple sclerosis therapies.
Special considerations when coding for patients with multiple sclerosis.
Multiple sclerosis in South America: month of birth in different latitudes does not seem to interfere with the prevalence or progression of the disease.
The human oligodendrocyte proteome.
Venous endothelial injury in central nervous system diseases.
"Response to the Commentary on "Neuromyelitis Optica: Potential Roles for Intravenous Immunoglobulin"
A case of multiple sclerosis and celiac disease.
A Randomized Controlled Pilot Trial: The Effects of EGb 761 on Information Processing and Executive Function in Multiple Sclerosis.
Aquaporin-4 antibody negative recurrent isolated optic neuritis: Clinical evidence for disease heterogeneity.
Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis.
Commentary on neuromyelitis optica associated with painful paroxysmal dystonia: case report and literature review.
Brainstem glioblastoma in a patient with secondary progressive multiple sclerosis.
Vitamin D levels in multiple sclerosis patients: Association with TGF-β2, TGF-βRI, and TGF-βRII expression.
Longitudinal associations between brain structural changes and fatigue in early MS.
Retinoic acid suppresses IL-17 production and pathogenic activity of γδ T cells in CNS autoimmunity.
The evolutionarily conserved Tre2/Bub2/Cdc16 (TBC), Lysin motif (LysM), Domain catalytic (TLDc) domain is neuroprotective against oxidative stress.
White and gray matter damage in primary progressive MS: The chicken or the egg?
Human adipose stromal/stem cells from obese donors show reduced efficacy in halting disease progression in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
Pages
« first
‹ previous
…
529
530
531
532
533
534
535
536
537
…
next ›
last »